Danyelza Market Report 2026
Download Free Sample Buy Now
Danyelza Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Danyelza Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Danyelza Market Overview

• The Danyelza market growth in the historic period has been driven by poor outcomes in relapsed neuroblastoma, advances in monoclonal antibody therapy

• Market expansion is supported by growth in pediatric cancer trials, expansion of immuno oncology pipelines

• Growth Driver: Market Growth Driven By Increasing Pediatric Cancer Cases

• Market Trend: Targeted Immunotherapy For Neuroblastoma And Beyond

• North America was the largest region in 2025.

What Is Covered Under Danyelza Market?

Danyelza, known as naxitamab, is a monoclonal antibody drug combined with granulocyte-macrophage colony-stimulating factor (GM-CSF) to treat certain high-risk cancers. It is primarily approved for pediatric patients aged 1 year and older and adults with relapsed or refractory high-risk neuroblastoma affecting the bone or bone marrow, particularly in cases where prior treatments achieved only partial or stable responses. Danyelza targets GD2, commonly found in neuroblastoma cells, enabling the immune system to attack these cancerous cells effectively.

The main types of indications in danyelza are neuroblastoma, osteosarcoma, and other GD2-positive cancers. Neuroblastoma is a type of cancer that develops in nerve cells, commonly affecting children, and danyelza, which is used for treating neuroblastoma, is growing as more therapies are approved for pediatric cancers. The treatment types, which include monotherapy, combination therapy, and end users, are categorized into hospitals, specialty clinics, and cancer and radiation therapy centers.

Danyelza Market Global Report 2026 Market Report bar graph

What Is The Danyelza Market Size and Share 2026?

The growth in the historic period can be attributed to poor outcomes in relapsed neuroblastoma, advances in monoclonal antibody therapy, orphan drug approvals, pediatric oncology specialization, clinical success of gd2 targeting.

What Is The Danyelza Market Growth Forecast?

The growth in the forecast period can be attributed to growth in pediatric cancer trials, expansion of immuno oncology pipelines, increased access to specialty cancer centers, supportive reimbursement policies, rising awareness of rare cancers. Major trends in the forecast period include growing adoption of targeted immunotherapy, rising use of gd2 directed treatments, expansion of pediatric oncology therapies, increased combination cancer treatment approaches, focus on refractory and relapsed cancers.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Danyelza Market Segmentation

1) By Indication: Neuroblastoma, Osteosarcoma And Other GD2-Positive Cancers

2) By Treatment Type: Monotherapy, Combination Therapy

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Center

What Is The Driver Of The Danyelza Market?

The increasing prevalence of pediatric cancers is expected to propel the growth of the danyelza market going forward. Pediatric cancers refer to cancers that occur in children and adolescents, including various types such as leukemia, brain tumors, neuroblastoma, and lymphomas. The increasing prevalence of pediatric cancers can be attributed to factors such as advances in diagnostic techniques, environmental exposures, genetic predispositions, and the long-term effects of cancer treatments. Danyelza (naxitamab) is a targeted immunotherapy that helps reduce the prevalence of pediatric cancers by effectively treating high-risk neuroblastoma. Its use in combination with other therapies has shown improved survival rates and reduced disease progression in children with this aggressive cancer. For instance, in October 2024, according to the Cancer Council, an Australia-based non-profit organization, in 2022, around 93 children aged 0-14 years in Australia died from cancer. Further, there were 206 cancer diagnoses in children under 15 and 263 in those aged 15-24 in Victoria. By 2023, there were 6,197 males and 5,523 females alive who had been diagnosed with cancer during childhood or adolescence. Therefore, the increasing prevalence of pediatric cancers is driving the growth of the danyelza industry.

Key Players In The Global Danyelza Market

Major companies operating in the danyelza market are Y-mAbs Therapeutics Inc.

Global Danyelza Market Trends and Insights

Major companies operating in the danyelza market are focusing on developing innovative formulations, such as targeted immunotherapy, to enhance therapeutic options and improve patient outcomes. Targeted immunotherapy refers to treatments that utilize substances to specifically target and attack cancer cells by focusing on proteins or markers, such as GD2 in neuroblastoma, thereby enabling the immune system to destroy malignant cells. For instance, in May 2023, Y-mAbs Therapeutics Inc., a US-based biotech company, received marketing authorization from Brazil's Agência Nacional de Vigilância Sanitária for Danyelza (naxitamab-gqgk) 40 mg/10 mL injection, a treatment for high-risk neuroblastoma. Danyelza is a recombinant humanized monoclonal antibody targeting GD2, a ganglioside prevalent in neuroectoderm-derived tumors and sarcomas, and was developed by Memorial Sloan Kettering Cancer Center under an exclusive license to Y-mAbs.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Danyelza Market?

In November 2024, Nobelpharma Co., Ltd., a Japan-based pharmaceutical company that develops curative drugs and medical devices, partnered with Y-mAbs Therapeutics Inc. Under the agreement, Nobelpharma will handle the development, regulatory submission, and marketing of DANYELZA in Japan, including sales and distribution, if approved. Y-mAbs Therapeutics Inc. is a US-based biotech company specializing in cancer immunotherapies, including DANYELZA.

Regional Insights

North America was the largest region in the danyelza market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Danyelza Market?

The danyelza market consists of sales of genetically modified donor pancreas cells, cell transplantation, and immune suppression drugs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Danyelza Market Report 2026?

The danyelza market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the danyelza industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Danyelza Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Indication, Treatment Type, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Y-mAbs Therapeutics Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Danyelza Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Danyelza Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Danyelza Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Danyelza Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Adoption Of Targeted Immunotherapy

4.2.2 Rising Use Of GD2 Directed Treatments

4.2.3 Expansion Of Pediatric Oncology Therapies

4.2.4 Increased Combination Cancer Treatment Approaches

4.2.5 Focus On Refractory And Relapsed Cancers

5. Danyelza Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Pediatric Oncology Centers

5.3 Specialty Cancer Clinics

5.4 Academic Medical Centers

5.5 Radiation Therapy Centers

6. Danyelza Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Danyelza Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Danyelza PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Danyelza Market Size, Comparisons And Growth Rate Analysis

7.3. Global Danyelza Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Danyelza Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Danyelza Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Danyelza Market Segmentation

9.1. Global Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neuroblastoma, Osteosarcoma And Other GD2-Positive Cancers

9.2. Global Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monotherapy, Combination Therapy

9.3. Global Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Cancer And Radiation Therapy Center

10. Danyelza Market Regional And Country Analysis

10.1. Global Danyelza Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Danyelza Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Danyelza Market

11.1. Asia-Pacific Danyelza Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Danyelza Market

12.1. China Danyelza Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Danyelza Market

13.1. India Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Danyelza Market

14.1. Japan Danyelza Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Danyelza Market

15.1. Australia Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Danyelza Market

16.1. South Korea Danyelza Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Danyelza Market

17.1. Western Europe Danyelza Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Danyelza Market

18.1. UK Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Danyelza Market

19.1. Germany Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Danyelza Market

20.1. France Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Danyelza Market

21.1. Eastern Europe Danyelza Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Danyelza Market

22.1. North America Danyelza Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Danyelza Market

23.1. USA Danyelza Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Danyelza Market

24.1. Canada Danyelza Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Danyelza Market

25.1. South America Danyelza Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Danyelza Market

26.1. Middle East Danyelza Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Danyelza Market

27.1. Africa Danyelza Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Danyelza Market, Segmentation By Indication, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Danyelza Market Regulatory and Investment Landscape

29. Danyelza Market Competitive Landscape And Company Profiles

29.1. Danyelza Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Danyelza Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Danyelza Market Company Profiles

29.3.1. Y-mAbs Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Danyelza Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Danyelza Market

32. Danyelza Market High Potential Countries, Segments and Strategies

32.1 Danyelza Market In 2030 - Countries Offering Most New Opportunities

32.2 Danyelza Market In 2030 - Segments Offering Most New Opportunities

32.3 Danyelza Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Danyelza Market, Overview Of Key Products - Product Examples
  • Table 2: Global Danyelza Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Danyelza Market, Supply Chain Analysis
  • Table 4: Global Danyelza Market, Major Raw Material Providers
  • Table 5: Global Danyelza Market, Major Resource Providers
  • Table 6: Global Danyelza Market, Major Manufacturers (Suppliers)
  • Table 7: Global Danyelza Market, Major Distributors And Channel Partners
  • Table 8: Global Danyelza Market, Key Technologies & Future Trends
  • Table 9: Global Danyelza Market, Major Trends
  • Table 10: Global Danyelza Market, Major End Users
  • Table 11: Global Danyelza Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Danyelza Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Danyelza Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Danyelza Market - TAM, US$ Billion, 2025
  • Table 15: Global Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Danyelza Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Danyelza Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Danyelza Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Danyelza Market - Company Scoring Matrix
  • Table 73: Y-mAbs Therapeutics Inc. Financial Performance
  • Table 74: Global Danyelza Market, Competitive Benchmarking (In USD Billions)
  • Table 75: Global Danyelza Market, Competitive Dashboard
  • Table 76: Global Danyelza Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 77: Global, Danyelza Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 78: Global, Danyelza Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 79: Global, Danyelza Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Danyelza Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Danyelza Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Danyelza Market, Supply Chain Analysis
  • Figure 4: Global Danyelza Market, Major Raw Material Providers
  • Figure 5: Global Danyelza Market, Major Resource Providers
  • Figure 6: Global Danyelza Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Danyelza Market, Major Distributors And Channel Partners
  • Figure 8: Global Danyelza Market, Key Technologies & Future Trends
  • Figure 9: Global Danyelza Market, Major Trends
  • Figure 10: Global Danyelza Market, Major End Users
  • Figure 11: Global Danyelza Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Danyelza Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Danyelza Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Danyelza Market - TAM, US$ Billion, 2025
  • Figure 15: Global Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Danyelza Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Danyelza Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Danyelza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Danyelza Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Danyelza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Danyelza Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Danyelza Market - Company Scoring Matrix
  • Figure 73: Y-mAbs Therapeutics Inc. Financial Performance
  • Figure 74: Global Danyelza Market, Competitive Benchmarking (In USD Billions)
  • Figure 75: Global Danyelza Market, Competitive Dashboard
  • Figure 76: Global Danyelza Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 77: Global, Danyelza Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 78: Global, Danyelza Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 79: Global, Danyelza Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Dru...

Dermatology Drugs Global Market Report 2022 – By Type (Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By R...

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others...

Frequently Asked Questions

The Danyelza market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Danyelza market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Danyelza market Include, Y-mAbs Therapeutics Inc. .

Major trend in this market includes: Targeted Immunotherapy For Neuroblastoma And Beyond. For further insights on this market. request a sample here

North America was the largest region in the danyelza market in 2025. The regions covered in the danyelza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us